Clinical trial
Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients…
NCT00488761 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00488761 |
|---|---|
| Title | Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI |
| Official title | A Multicenter, Open Label Study to Evaluate the Safety and Efficacy of Tigecycline to Treat Complicated Skin and Skin Structure Infections (cSSSI) in Hospitalized Patients |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Skin Diseases, Infectious |
| Intervention type | Drug |
| Interventions | Tigecycline |
| Enrollment | 50 |
| Start date | Jul 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Jun 20, 2007 |
| Last update posted | Dec 28, 2007 |
| Countries | Taiwan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: